Gentian Diagnostics ASA (OSL:GENT)

Gentian Diagnostics ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	870	605	640	632	1,110	840
Market Cap Growth	18.52%	-5.54%	1.22%	-43.06%	32.20%	-12.61%
Enterprise Value	793	517	574	555	1,000	691
Last Close Price	56.40	38.88	41.17	40.67	71.42	54.06
PE Ratio	21.32	13.35	-	-	-	-
Forward PE	34.99	28.52	-	-	-	-
PS Ratio	5.32	3.98	4.74	5.65	11.10	10.65
PB Ratio	4.41	3.12	4.37	4.10	6.35	4.32
P/TBV Ratio	5.24	3.65	5.10	4.97	7.42	4.32
P/FCF Ratio	45.14	50.05	44.13	-	-	-
P/OCF Ratio	43.72	44.93	41.40	-	-	-
EV/Sales Ratio	4.85	3.40	4.24	4.96	10.00	8.75
EV/EBITDA Ratio	29.89	27.82	-	-	-	-
EV/EBIT Ratio	40.09	32.91	-	-	-	-
EV/FCF Ratio	41.14	42.83	39.55	-	-	-
Debt / Equity Ratio	0.02	0.05	0.09	0.10	0.11	0.11
Debt / EBITDA Ratio	0.12	0.45	-	-	-	-
Debt / FCF Ratio	0.16	0.83	0.90	-	-	-
Asset Turnover	0.78	0.74	0.73	0.56	0.45	0.34
Inventory Turnover	1.61	1.67	1.87	1.54	1.71	1.67
Quick Ratio	3.78	3.85	4.13	4.58	6.10	7.67
Current Ratio	5.47	5.38	5.60	6.33	7.42	8.59
Return on Equity (ROE)	23.78%	26.59%	-7.08%	-14.36%	-13.43%	-8.67%
Return on Assets (ROA)	5.91%	4.78%	-4.32%	-7.27%	-6.39%	-4.82%
Return on Capital (ROIC)	6.76%	5.40%	-4.85%	-8.00%	-6.96%	-5.19%
Return on Capital Employed (ROCE)	9.90%	7.90%	-	-	-	-
Earnings Yield	4.85%	7.49%	-1.66%	-3.74%	-2.23%	-2.08%
FCF Yield	2.22%	2.00%	2.27%	-3.57%	-2.53%	-1.81%
Dividend Yield	0.71%	1.03%	-	-	-	-
Buyback Yield / Dilution	-3.52%	-2.21%	-	-0.04%	-0.07%	-0.01%
Total Shareholder Return	-2.80%	-1.18%	-	-0.04%	-0.07%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.